Multi-hormone agents like retatrutide combining GLP-1, GIP, and glucagon
Some studies suggest that GLP-1 drugs may have mild anti-inflammatory properties, which could benefit those with inflammatory conditions like lupus, though further research is required
133 These findings raise concerns about its reliability as a universal CSC marker
World J Diabetes 7:572598 Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ, Husain M (2008) Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and independent pathways
For example, the open-label mB12/LDFA study selected individuals with poor glutathione and methylation status to potentiate the ability of the treatment to change these parameters (James et al., Like the participants in the mB12/LDFA study, participants in the BH4 study demonstrated some less favorable biomarkers at baseline, but these biomarkers were related to chronic oxidative stress and inflammation
If not, well guide you toward the best next step for your health
